Abstract: Croton cajucara Benth. ('sacaca') is a tree of the Euphorbiaceae family, native to the Amazon region in northern Brazil, where it is widely used in the popular treatment of various diseases. Its active principle, the terpenoid transdehydrocrotonin, has been credited with a variety of medical properties, including antiulcer, antiinflammatory, antitumor, antimutagenic and hypoglycemic activity. In this investigation, possible mutagenic and antimutagenic effects were evaluated in treatments using methanol extract of this plant on Swiss Albino mice by examining their peripheral blood cells for micronuclei. In these tests, the material obtained by methanol extraction of C. cajucara tree bark was administered to the mice by gavage. None of the doses evaluated in this study presented mutagenicity. Analysis of the results obtained from studies evaluating antimutagenicity revealed protection against the chemotherapeutic agent cyclophosphamide for the two highest doses used.
Introduction
Many compounds produced by secondary metabolism in plants can act as mutagens/carcinogens or, conversely, as carcinogen inhibitors (Ames 1983; Kritchevsky 1983; Kusamnram et al. 1998; Agner et al. 2001) . Inhibitory activity of this type plays an important part in the prevention of cancer and other degenerative diseases. Such treatments, known as chemoprevention (Rosin 1992) , may involve the consumption of protective substances as part of the diet or in prepared remedies (De Flora 1998) . The literature presents several studies that show antimutagenic effects for compounds obtained from vegetable species (Bruni et al. 2006; Barcelos et al. 2007; Cariño-Cortés et al. 2007) .
Croton cajucara Benth. (family Euphorbiaceae) is a tree endemic to the Brazilian Amazonia, known locally as sacaca. It is very popular in northern Brazil in the form of infusions and tablets as a treatment for a variety of diseases, including malaria, diarrhoea and cancer. Maciel et al. (1998) reported that the active principle is the norclerodane diterpene, transdehydrocrotonin (DCTN), which is abundant in the bark of adult trees (over 3 years old). DCTN has been reported to present antimutagenic (Agner et al. 2001; Poersch et al. 2007) , antitumor (Grynberg et al. 1999) , antiulcer (Brito et al. 1998) , antiinflammatory (Carvalho et al. 1996) and hypoglycemic (Farias et al. 1997) properties.
The opinions concerning the use of C. cajucara derivatives are ambiguous. They vary from diverse beneficial effects and the great popularity of infusions of its bark in traditional medicine to the paucity of studies on crude extracts from this plant and reports from public hospitals in the city of Belém (PA, Brazil) of several individuals developing toxic hepatitis after drinking excessively strong sacaca bark tea (Maciel et al. 1998 ). In the light of the above, it is clearly important to evaluate both its toxic and protective potential in relation to mammalian DNA. Thus, the aim of this work was to investigate the mutagenic and antimutagenic properties of a methanol extract (ME) of C. cajucara, using the micronucleus test on the peripheral blood of mice submitted subchronic treatments. 
Material and methods

Animals
Five to six week-old albino Swiss mice (Mus musculus), weighing approximately 30 g, from the Central Animal Facility of the State University of Londrina (Parana, Brazil) were kept individually in polypropylene cages following the conditions for animal care recommended by the Canadian Council on Animal Care (Olfert et al. 1993) .
The mice were divided into groups of 10 (5 males and 5 females) for each treatment. The animals were treated with 0.1 mL of each of the solutions used per 10 g body weight and received water and food ad libitum throughout the treatment period.
Plant extract
The methanol plant extract obtained from native Croton cajucara tree bark, collected in Jacunda, Pará state (Amazon region) was used. The plant was identified by Nelson A. Rosa and a voucher specimen (no. 247) was deposited in the Emilio Goeldi Paraense Museum (Belém, Brazil). Methanol extraction was carried out on ground-powdered bark via Soxhlet, for 48 hours.
The plant extract was diluted in DMSO solution (dimethyl sulfoxide, CAS: 67-68-5) and water at a ratio of 2:1 and administered to the mice via gavage at doses of 312.5, 625 or 1,250 mg/kg body weight (b.w.).
Treatment of animals
Ten treatment groups of mice were chosen to evaluate possible mutagenic and antimutagenic activities of sacaca bark ME. An internal control was established for each animal by preparing a test slide with a drop of blood taken from its tail, prior to the first treatment (time T0).
Mice in group 1 (positive control) were injected intraperitoneally with 150 mg/kg b.w. cyclophosphamide (CP), while group 2 (negative control) received distilled water and group 3 (solvent control) DMSO + water (2:1), both by gavage. Mice in groups 4, 5 and 6 received the ME by gavage at doses of 312.5, 625 and 1,250 mg/kg b.w., respectively. Group 7 received DMSO + water by gavage, together with injected CP, as a solvent control for the antimutagenicity test, and groups 8, 9 and 10 were administered the same doses of ME as groups 4, 5 and 6, respectively, in association with CP treatment, to evaluate possible antimutagenic activity of the extract.
In traditional medicine, vegetable products are recommended for the treatment of numerous diseases and repeated doses over several days or weeks are common. Thus, a treatment schedule involving repeated doses was chosen to assess the risks (mutagenicity) and/or efficiency (antimutagenicity) of the vegetable extract.
Mutagenicity test
To evaluate the mutagenic effect of the ME on mouse peripheral blood reticulocytes, the mice from the groups 4, 5 and 6 were treated via gavage on days 0, 7, 14 and 21, totaling four doses. Blood samples were taken on days 0, 7, 14, 21 and 28, to detect any possible mutagenic effect of subchronic treatment with the ME.
Antimutagenicity test
The test for antimutagenic activity of C. cajucara was designed to expose the reticulocytes to the concomitant action of the ME and a mutagenic agent. Thus, CP was injected into the peritoneum of mice in groups 8, 9 and 10, one hour after they had received the doses of ME by gavage (312.5, 625 and 1,250 mg/kg b.w., respectively), in order that the ME components, which needed to enter the bloodstream by passing through the wall of the digestive tract, would reach the blood cells simultaneously with the CP. In the solvent control group for this test (group 7), CP was injected one hour after the administration of DMSO + water by gavage. The mice received repeated doses of the C. cajucara extract in association with CP, on days 0, 7, 14 and 21, as in the test to detect ME mutagenicity. Blood samples were taken on the days 0, 7, 14, 21 and 28, to detect any possible antimutagenic effect of subchronic treatment with the extract.
Micronucleus test
The micronucleus test on peripheral blood cells was performed according to the protocol described by Hayashi et al. (1990) , in which slides pre-stained with acridine orange (CAS: 494-38-2) are used. Glass slides were heated to about 70
• C on a hot-plate and a 10 µL drop of an aqueous solution of the dye (1 mg/mL) was placed on each slide and spread evenly over the surface with the end of a second well-cleaned slide. Once dry, the slides were maintained in the dark at room temperature for at least 24 h.
Blood was obtained by perforating the caudal vein of the mice with a needle through which 5 µL drops were collected and then placed at the centre of a pre-stained slide and covered with a cover-slip (24 × 40 mm). These slides were maintained in the dark at −20
• C, for a minimum of 24 h, prior to cytological examination of the blood cells.
The cell preparations were examined under a fluorescence microscope (Nikon), with a blue (488 nm) excitation filter and yellow (515 nm) emission (barrier) filter, using an immersion objective. 1,000 reticulocytes per treated animal were analyzed and the proportion of micronucleated cells determined.
Statistical analysis
The data obtained from the cytological examination were subjected to the transformation y = √ x + 0.5. Based on the transformed values, mean frequencies of micronucleated cells and standard deviations were calculated for each treatment group; Analysis of Variance (ANOVA) and the Student t test were then applied.
Results
Table 1 displays the micronucleated reticulocyte (MN-RET) frequency observed after each of the treatments carried out. Observation shows that the mean MNRET frequency remained unaltered, relative to the internal control (sample at T 0 ), by any of the three ME doses used to treat the mice, at any of the successive samplings (T 1 to T 4 ). Moreover, when the data for the extract-treated groups at any sampling time were statistically compared with the negative control value for that time, no change in the mean MNRET frequency was found. This revealed the absence of any mutagenic effect produced by the ME treatment.
In the positive-control group, treated with weekly doses of CP (150 mg/kg b.w.), the MNRET frequencies observed in samplings at T 1 , T 2 , T 3 and T 4 (7, 14, 21 and 28 days, respectively) were all higher than that at T 0 ; prior to any treatment. When these frequencies were compared with those observed at the same times in the negative-control group, the increases observed were CP (150) 1.1 ± 0.7 2.3 ± 1.2 a 3.2 ± 1.6 a 2.7 ± 1.6 a 2.5 ± 1.1 a Water 1.2 ± 0.9 0.9 ± 0.7 1.1 ± 0.7 1.0 ± 0.7 0.9 ± 0.7 Solvent 1.4 ± 0.8 1.0 ± 0.9 1.2 ± 0.9 1.6 ± 1.1 1.3 ± 1.0 Extract 312.5 1.2 ± 0.9 1.5 ± 1.3 0.9 ± 0.7 1.2 ± 0.8 1.3 ± 0.9 625 1.0 ± 0.8 0.9 ± 1.0 1.4 ± 0.7 1.2 ± 0.7 1.6 ± 1.1 1250.0 0.9 ± 0.7 1.0 ± 0.8 1.4 ± 0.7 1.0 ± 1.0 1.4 ± 0.7 a Statistically different from T 0 in the same treatment group (P < 0.05) after transformation of data. CP (150) 1.1 ± 0.7 2.3 ± 1.2 3.2 ± 1.6 2.7 ± 1.6 2.5 ± 1.1 Solvent+CP 0.9 ± 0.9 3.4 ± 1.7 1.9 ± 1.5 2.1 ± 1.2 1.8 ± 0.9 Extract+CP 312.5 + CP 0.8 ± 0.9 1.4 ± 1.4 2.6 ± 0.8 a 1.0 ± 1.0 a 1.5 ± 1.1 a 625 + CP 1.1 ± 0.9 1.1 ± 1.1 a 1.7 ± 1.1 a 1.1 ± 1.0 a 1.5 ± 0.8 a 1250.0 + CP 0.9 ± 0.9 1.3 ± 0.9 a 1.7 ± 1.2 a 1.0 ± 0.7 a 1.3 ± 0.9 a a Statistically different from the cyclophosphamide group in the same sampling time (P < 0.05) after the transformation of data.
quite marked, proving the efficacy of the test model used. Groups treated with the vegetable extract associated with the CP presented lower MNRET frequencies than the CP group, indicating that the ME was associated with a reduction in the number of MNRETs induced by the chemotherapeutic agent (Table 2) . In mice treated with the lowest ME dose (312.5 mg/kg b.w.), this reduction was significant after three weeks of treatment (at T 3 and T 4 ), while in the groups that received higher doses (625 and 1,250 mg/kg b.w.), a reduction in induced MNRETs occurred from the first week onward (T 1 , T 2 , T 3 and T 4 ).Thus, in the experimental model used here, the ME was shown to possess antimutagenic activity, particularly at the two higher doses administered to the mice.
Discussion
The genus Croton includes around 900 species worldwide and a wide selection of these plants are native to the north and north-eastern regions of Brazil (Ducke 1959) , where many of them are used in traditional medicine (Craveiro et al. 1981) . However, a number of Croton species are known to present carcinogenic and irritating effects due to the presence of phorbol diterpene esters among their chemical constituents (Hecker & Schmidt 1974; Weber & Hecker 1978) . In previous studies (Maciel et al. 1998) , our group found no harmful compounds in Croton cajucara, which may explain the apparent absence of toxic effects in derivatives of this plant when used in moderation. In fact, C. cajucara has demonstrated enormous pharmacological potential, attributed mainly to the diverse biological properties cited for its active principle, DCTN.
The essential oil obtained from sacaca has proven effective at protecting against the action of gastric ulcer-inducing agents (Hiruma-Lima et al. 2000) and exhibited antiinflammatory activity in animal models (Bighetti et al. 1999 ). Such results demonstrate that not only DCTN, but also other components extracted from C. cajucara, possess a variety of important biological properties and it must be emphasized that the study of all these activities, including possible mutagenic and antimutagenic actions, will provide valuable information to apothecaries and the public alike. Moreover, when crude extracts that present different compounds are studied, the data obtained can reflect possible interactions between the various chemical components present in the vegetable extract. This interaction may lead to responses that are distinct from those obtained using the purified active principles, as detected by our group (Santos et al. 2006a ) when studying extracts and fractions of Strychnos pseudoquina, another medicinal plant.
In the work reported in this paper, the potential mutagenic and antimutagenic effects of the ME on mouse peripheral blood cells were tested after subchronic treatments, since herbal treatments based on C. cajucara involve the ingestion of infusions and tablets prepared from its bark that are taken over long periods (Maciel et al. 1998) . The infusion process mainly extracts polar compounds; thus, the effects of the ME were chosen for assessment, since it is rich in polar substances.
In vivo studies regarding DCTN, the active principle of sacaca (Agner et al. 1999) and regarding the ME (Santos et al. 2006b ) revealed no mutagenic effect. The data presented in this paper also show an absence of mutagenicity for the C. cajucara bark ME, at all three concentrations administered to the mice during subchronic treatments.
C. cajucara bark ME exhibited antimutagenic properties, protecting the mouse cells from CP genotoxicity (150 mg/kg b.w.; intraperitoneal). CP is a chemotherapeutic agent and immune suppressor that acts as potent alkylant agent after its metabolic activation, which occurs predominantly in the liver. It is recommended for use as positive control agent in mutagenicity tests because of its chemotherapeutic action (Preston et al. 1987) .
The results showed that the frequencies of micronucleated cells in the positive control were higher at T 2 (day 14) and decreased at T 3 and T 4 (days 21 and 28, respectively). This probably occurred due to an increase in cell death derived from the accumulation of DNA damage (micronucleus) previously induced in bone marrow stem cells. A similar effect was observed in a study realized by Vodicka et al. (2001) . In their study on mice, the inhalation of styrene (a cytotoxic and genotoxic compound) caused an increase in frequency similar to values observed in the negative control.
In mice treated with the lowest dose of the ME (312.5 mg/kg b.w.) in association with CP, this protective effect occurred only after three weeks of treatment, such that the MNRET frequencies in blood collected at T 4 and T 5 were lower compared to samples taken from CP-treated mice (group 1) at the same times. The need for a period of three weeks for this dose to take effect suggests that the constituents of the ME present a cumulative effect and that this concentration of ME was close to its antimutagenicity threshold, under the experimental conditions. This suggestion is reinforced by the results obtained using the two higher ME doses (625 and 1,250 mg/kg b.w.), which were more effective at protecting mouse cells, reducing the rates of MNRET induction by CP in groups 9 and 10 compared to the rates for group 1, at all sampling times, from the first week of subchronic treatment (T 1 , T 2 , T 3 and T 4 ). No significant difference occurred between the degrees of protection produced by these two doses. Hence, the intermediate dose of 625 mg/kg b.w. is sufficient to provide effective protection against DNA damage induced by CP. These data corroborate the antimutagenicity that Agner et al. (2001) reported after administering a single dose of the active principle DCTN, via gavage.
We believe that the principal mechanism involved in the antimutagenic effect of C. cajucara is desmutagenesis; inactivation of the mutagen. Table 2 shows that the ME (312.5 mg/kg) diminished MNRET frequency; such that the values were statistically different from the negative control. This could indicate that CP was partially inactivated prior to damaging cell DNA. At the sampling times where the values of the treated groups were statistically equal to the negative control, it can be inferred that CP was totally inactivated prior to causing DNA damage (micronucleus).
In conclusion, the data presented here are reassuring regarding the popular consumption of sacaca extracts, since no sign of mutagenic activity in the ME was found under the experimental conditions used. From the same extracts, Maciel et al. (2000) isolated clerodane diterpenes, which, according to published reports (Odek-Ogunde & Rajab 1994; Farias et al. 1997; Maciel et al. 2002) , exhibit various therapeutic properties. The efficiency of C. cajucara ME in reducing the damage induced by CP is an important indication that this plant could be useful in the prevention of degenerative diseases caused by DNA damage. Humans are constantly exposed to mutagenic agents present in the air, water and food, among others. The discovery of natural compounds that can protect us against such agents is very important.
